SCHEMBL20054517

SCHEMBL20054517

CC(C)(C)OC(=O)NC(c1nc2ccc(C#Cc3ccc4nc([C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)[nH]c4c3)cc2[nH]1)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.49
LCK P06239 1/20 0.41
CFB P00751 3/20 0.41
GABRA1 P14867 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
SCN10A Q9Y5Y9 4/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
PIN1 Q13526 1/20 0.38
PTPN1 P18031 1/20 0.38
CYP1A2 P05177 1/20 0.37
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15116752 1.00 AAK1 (0.49) AAK1LCKCFBGABRA1GABRG2
SCHEMBL15116592 0.96 AAK1 (0.48) AAK1LCKCFBGABRA1GABRG2
SCHEMBL20054403 0.96 AAK1 (0.48) AAK1LCKCFBGABRA1GABRG2
SCHEMBL16391185 0.95 AAK1 (0.48) AAK1LCKCFBGABRA1GABRG2
SCHEMBL20054461 0.94 AAK1 (0.46) AAK1LCKCFBGABRA1GABRG2
SCHEMBL15116854 0.94 AAK1 (0.46) AAK1LCKCFBGABRA1GABRG2
SCHEMBL16409178 0.90 AAK1 (0.44) AAK1LCKCFBGABRA1GABRG2
SCHEMBL20221495 0.89 AAK1 (0.45) AAK1LCKCFBGABRA1GABRG2
SCHEMBL15116595 0.89 AAK1 (0.45) AAK1LCKCFBGABRA1GABRG2
SCHEMBL20054545 0.86 AAK1 (0.64) AAK1LCKSCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed